AI for Life Sciences
Compress the paperwork between discovery and market.
Pharma, biotech, and med-device companies run on documentation: protocols, submissions, quality records, literature. We build AI systems that make that corpus searchable, draft-ready, and audit-proof — accelerating the work between the science and the approval.
How is AI used in life sciences?
In life sciences, AI accelerates the documentation between discovery and market: drafting support and cross-reference checking on regulatory submissions, automated deviation and CAPA workflows with full traceability, and searchable access to internal studies, literature, and regulatory correspondence. Mufasa Labs builds these systems for GxP environments, with the qualification and audit documentation that validated settings require.
What makes it hard
The realities of AI in life sciences
Document mountains
Regulatory submissions, SOPs, batch records, and study documents multiply faster than teams can manage them.
GxP changes the rules
Validated environments and 21 CFR Part 11 expectations mean AI tools need qualification, not just installation.
Literature outpaces humans
Relevant publications, trial results, and safety signals appear faster than any team can read them.
What we build
Use cases with owners, timelines, and numbers
Each of these maps to a system we've built before — scoped to your stack in a 30-minute call.
Regulatory document intelligence
Drafting support and cross-reference checking across submissions, amendments, and responses — grounded in your prior filings.
Custom AI Development →Quality record automation
Deviation intake, CAPA documentation, and batch record review workflows automated with full traceability.
Workflow Automation →Scientific knowledge search
Internal studies, literature, and regulatory correspondence searchable in one governed surface.
Enterprise Search & RAG →Validated AI governance
Risk-tiered controls and documentation that hold up in a GxP audit.
AI Governance & Security →Outcomes
What good looks like
faster authoring cycles on regulatory documents
less time hunting for prior submissions and precedents
traceability on AI-assisted quality workflows
FAQ
AI in life sciences: common questions
Can AI be used in GxP-validated environments?
Yes, with qualification rather than just installation. AI systems in validated environments need documented risk assessment, evaluation records, and controls aligned to 21 CFR Part 11 expectations — deliverables we build into the engagement, not afterthoughts.
How does AI help with regulatory submissions?
Drafting support grounded in your prior filings, cross-reference checking across submissions and amendments, and instant retrieval of precedents and correspondence. Authors stay in control; the AI removes the hunting and consistency-checking that consumes authoring cycles.
Is AI-assisted quality documentation traceable enough for an audit?
It has to be, or it doesn't ship. Deviation intake, CAPA documentation, and batch record review workflows are automated with full traceability — every AI-assisted step logged with inputs, outputs, and approvals.
How do teams keep up with literature using AI?
A governed search surface over internal studies, external literature, and safety signals lets scientists ask questions in plain language and get cited answers — surfacing relevant publications faster than any manual review cycle.
Deployed in your cloud, on your stack
How to start
Book a 30-minute call with an engineer who's worked in life sciences-adjacent environments. You'll leave with an honest feasibility read — whether or not you hire us.
